Review of available studies of the neurobiology and pharmacotherapeutic management of trichotillomania
Keywords: Trichotillomania (TTM), Neurobiology, Rating scales, Clinical trials Authors: Jacklyn Johnson, Abir T. El-Alfy License: © 2015 Production and hosting by Elsevier B.V. on behalf of Cairo University. CC BY-NC-ND 4.0 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Article links: DOI: 10.1016/j.jare.2015.05.001 | PubMed: 26966559 | PMC: PMC4767796 Relevance: Moderate: mentioned 3+ times in text Full text: PDF (652 KB) Introduction Originally described by Hallopeau in 1889, trichotillomania (TTM) is a psychiatric disorder that is
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
